Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
670 people get RMD articles and Market Currents by email alert.
Get email alerts on RMD »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Got Growth? These 5 Stocks DoJohn Reese • Tue, May 7 -
-
PR Newswire (Apr 25, 2013)
-
PR Newswire (Apr 25, 2013)
-
-
-
PR Newswire (Apr 3, 2013)
-
PR Newswire (Mar 28, 2013)
-
-
-
-
PR Newswire (Feb 21, 2013)
-
-
PR Newswire (Jan 24, 2013)
-
-
-
-
-
-
-
-
Earnings Preview: ResMedTheflyonthewall • Thu, Feb 5, 2009 -
ResMed: Record Quarterly Revenues, Great ValuationsZacks Investment Research • Wed, Nov 26, 2008 -
Earnings Preview: ResMedTheflyonthewall • Wed, Nov 5, 2008
-
Resmed: Recall of Defective Units Eating Into ProfitsZachary Scheidt • Fri, Jun 8, 2007
-
-
Got Growth? These 5 Stocks DoJohn Reese • Tue, May 7
-
-
-
-
-
7 High Growth Healthcare Stocks With Strong Inventory TrendsKapitall • Wed, Dec 12, 2012
-
Obamacare Can Learn From These Healthcare StocksGreg Group • Fri, Oct 19, 2012 -
3 Highly Liquid Mid Cap Stocks Churning Out ProfitsZetaKap • Thu, Oct 11, 2012 -
10 High-Growth Healthcare Stocks With Strong Inventory TrendsKapitall • Tue, Sep 18, 2012
-
4 Medical Device Stocks Undervalued By EPS TrendsKapitall • Thu, Sep 6, 2012
-
7 Highly Liquid Mid Cap Stocks That Analyst Rate As BuyZetaKap • Wed, Aug 22, 2012
-
5 High-Growth Medical Device Stocks With Strong Inventory TrendsKapitall • Mon, Jul 30, 2012
-
12 Highly Liquid Healthcare Stocks With Strong Sales TrendsKapitall • Tue, Jul 3, 2012
-
-
-
9 High-Growth Healthcare Stocks With Strong Inventory TrendsKapitall • Thu, May 17, 2012
-
7 Rallying Healthcare Stocks Being Sold Off By Hedge FundsKapitall • Fri, May 11, 2012
-
-
12 High-Growth Healthcare Stocks With Strong Inventory TrendsKapitall • Thu, Apr 26, 2012
-
ResMed Management Discusses Q1 2013 Results - Earnings Call TranscriptThu, Oct 25, 2012
-
ResMed's CEO Discusses Q3 2012 Results - Earnings Call TranscriptThu, Apr 26, 2012
-
ResMed's CEO Discusses F2Q12 Results - Earnings Call TranscriptThu, Jan 26, 2012
-
ResMed's CEO Discusses F1Q 2012 Results - Earnings Call TranscriptMon, Oct 24, 2011
-
ResMed's CEO Discusses Q4 2011 Results - Earnings Call TranscriptThu, Aug 4, 2011
-
ResMed F2Q10 (Qtr End 12/31/09) Earnings Call TranscriptThu, Feb 4, 2010
-
ResMed Inc. Q1 2010 Earnings Call TranscriptThu, Nov 5, 2009
-
ResMed Inc. F4Q09 (Qtr End 6/30/09) Earnings Call TranscriptThu, Aug 6, 2009
-
ResMed F3Q09 (Qtr End 3/31/09) Earnings Call TranscriptThu, May 7, 2009
-
ResMed, Inc. F2Q09 (Qtr End 12/31/08) Earnings Call TranscriptThu, Feb 5, 2009
-
ResMed Inc. F1Q09 (Qtr. End 09/30/08) Earnings Call TranscriptFri, Nov 7, 2008
-
ResMed, Inc. F4Q08 (Qtr. End 06/30/08) Earnings Call TranscriptWed, Aug 6, 2008
-
ResMed, Inc. F3Q08 (Qtr. End 03/31/08) Earnings Call TranscriptFri, May 2, 2008
-
ResMed, Inc. F2Q08 (Qtr. End 12/31/07) Earnings Call TranscriptThu, May 1, 2008
-
PR Newswire (Apr 25, 2013)
-
PR Newswire (Apr 25, 2013)
-
PR Newswire (Apr 3, 2013)
-
PR Newswire (Mar 28, 2013)
-
PR Newswire (Feb 21, 2013)
-
PR Newswire (Jan 24, 2013)
-
PR Newswire (Jan 8, 2013)
-
PR Newswire (Nov 21, 2012)
-
PR Newswire (Oct 25, 2012)
-
PR Newswire (Oct 2, 2012)
-
PR Newswire (Sep 24, 2012)
-
at MarketWatch.com (Sep 23, 2012)
-
PR Newswire (Aug 27, 2012)
-
at Fox Business (Aug 21, 2012)
-
at Fox Business (Aug 21, 2012)
-
at Fox Business (Aug 21, 2012)
-
ResMed Inc. Announces Record Financial Results For The Quarter And Twelve Months Ended June 30, 2012PR Newswire (Aug 2, 2012)
-
PR Newswire (Jun 28, 2012)
-
PR Newswire (Jun 13, 2012)
RMD vs. ETF Alternatives
Company Description
We are a leading developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. Sleep-disordered breathing, or SDB, includes obstructive sleep apnea, or OSA, and other respiratory disorders that... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Friday, April 26, 3:38 PM Shares of Resmed (RMD +1.4%) moves up after its FQ3 bottom line EPS came in better than Street estimates late yesterday. Net income jumped 31% Y/Y, driven by strong sales performance out of its Americas segment. Separately, Goldman Sachs adds the stock to its Conviction List on the back of the results. Comment! [Healthcare, Earnings, On the Move]
- Thursday, April 25, 4:21 PM ResMed (RMD): FQ3 EPS of $0.58 beats by $0.02. Revenue of $383.6M (+10% Y/Y) misses by $4.08M. Shares -3.4% AH. (PR) Comment! [Earnings, Breaking News, Healthcare, On the Move]
- Thursday, April 25, 9:27 AM ResMed (RMD) says a device designed to reduce hospital readmission rates for COPD patients is cleared by the FDA and is now available. The company reports today after the bell. Comment! [Healthcare]
- Thursday, April 25, 12:10 AM Notable earnings after Thursday’s close: AEM, ALTR, AMCC, AMKR, AMZN, BIDU, BJRI, BLDR, BMRN, CALX, CAMP, CB, CBG, CENX, CERN, CINF, CLWR, CRUS, CSTR, CTCT, DECK, DLB, ELY, EMN, EXPE, FII, FR, FSL, GERN, IGT, IM, INAP, INFA, KBR, KEG, KLAC, LEG, MCRS, MXIM, N, NR, NTGR, OLN, PFG, PKI, PMCS, QLIK, RMD, RRC, RSG, SBUX, SIMO, SPN, SWKS, SYNA, TCO, THRX, TLAB, UHS, VPRT, VRSN, WRE, WYNN Comment! [Earnings]
- Wednesday, April 24, 5:35 PM Notable earnings after Thursday’s close: AEM, ALTR, AMCC, AMKR, AMZN, BIDU, BJRI, BLDR, BMRN, CALX, CAMP, CB, CBG, CENX, CERN, CINF, CLWR, CRUS, CSTR, CTCT, DECK, DLB, ELY, EMN, EXPE, FII, FR, FSL, GERN, IGT, IM, INAP, INFA, KBR, KEG, KLAC, LEG, MCRS, MXIM, N, NR, NTGR, OLN, PFG, PKI, PMCS, QLIK, RMD, RRC, RSG, SBUX, SIMO, SPN, SWKS, SYNA, TCO, THRX, TLAB, UHS, VPRT, VRSN, WRE, WYNN Comment! [Earnings]
-
Thursday, January 31, 9:13 AM
Premarket gainers: ORCC +82%. WMS +55%. FTNT +20%. SGMS +15%. JDSU +14%. KERX +14%. ALGN +13%. SWKS +13%. CTXS +12%. ERIC +11%. DCTH +7%. PBI +8%. QCOM +6%. ALU +6%. CXS +6%. FNSR +6%. LVS +6%. UA +5%. IGT +5%.
Losers: CLSN -79%. LQDT -15%. FIO -14%. RIMM -7%. AFFY -7%. RMD -6%. FB -6%. VNR -5%. 1 Comment [On the Move] -
Wednesday, January 30, 5:43 PM
After-hours top gainers, as of 5:15 p.m.: FTNT +16%. CTXS +11%. ALGN +10%. SWKS +9%. NOW +8%.
After-hours top losers: FIO -20%. FSL -13%. MANH -7%. CNQR -6%. RMD -5%. Comment! [On the Move] - Friday, January 25, 11:25 AM ResMed (RMD +4.8%) moves up this morning after its FQ2 easily topped estimates late yesterday. Net earnings rose 24% Y/Y as the respiratory-device maker's revenue jumped, particularly in its Americas segment where it posted a 16% jump in sales, while revenue outside the Americas increased 10%. The better sales masked an increase in overall expenses for the quarter, with SG&A costs moving up 7%, largely due to a ramp-of its sales force, and R&D expenses rising by 11%. Comment! [Healthcare, Earnings, Global & FX, On the Move]
-
Thursday, January 24, 5:42 PM
After-hours top gainers, as of 5:15 p.m.: TPX +18%. INFA +12%. RMD +6%. KLAC +3%. QIHU +3%.
After-hours top losers: SCSS -17%. FLEX -7%. SFL -6%. ETFC -5%. CPHD -4%. Comment! [On the Move] - Thursday, January 24, 4:13 PM ResMed (RMD): FQ2 EPS of $0.53 beats by $0.02. Revenue of $376.5M (+13% Y/Y) beats by $12.74M. Shares +4% AH. (PR) Comment! [Earnings, On the Move, Breaking News, Healthcare]
- Thursday, January 24, 12:10 AM Notable earnings after Thursday’s close: CPHD, CRUS, ED, EGHT, ETFC, FLEX, INFA, JBHT, JNPR, KLAC, MSFT, MXIM, QLGC, RMBS, RMD, SBUX, SCSS, SXL, SYNA, T, TKR, TPX, VRSN 1 Comment [Earnings]
- Wednesday, January 23, 5:35 PM Notable earnings after Thursday’s close: CPHD, CRUS, ED, EGHT, ETFC, FLEX, INFA, JBHT, JNPR, KLAC, MSFT, MXIM, QLGC, RMBS, RMD, SBUX, SCSS, SXL, SYNA, T, TKR, TPX, VRSN Comment! [Earnings]
- Thursday, October 25, 2012, 4:41 PM ResMed (RMD): FQ1 EPS of $0.49 beats by $0.02. Revenue of $339.7M (+8% Y/Y) misses by $2M. (PR) Comment! [Earnings, Healthcare]
- Thursday, August 2, 2012, 6:30 PM ResMed (RMD): Q2 EPS of $0.53 beats by $0.04. Revenue of $372M (+8.8% Y/Y) beats by $4M. (PR) Comment! [Earnings, Healthcare]
- Friday, April 27, 2012, 2:19 PM ResMed (RMD +7%) trades up after beating FQ3 consensus estimates late yesterday. Net income jumped 21% Y/Y, driven by higher-than-expected gross margins from strong growth in masks and a shift to higher-margin flow generators. Separately, Goldman ups the shares to Buy on the back of the blowout quarter. Comment! [Healthcare, Earnings, On the Move]
- Thursday, April 26, 2012, 6:14 PM ResMed (RMD): FQ3 EPS of $0.44 beats by $0.03. Revenue of $349M (+11.5% Y/Y) beats by $10M. Shares +5.3% AH. (PR) Comment! [Earnings, Healthcare, On the Move]
-
- View all 1 replies
-
-
- View all 0 replies
-
- View all 0 replies
-
Ryan Mallory
LiveCharts: Don't Jump The Gun | $DPZ $SLV and $RMD are the top setups discussed. http://bit.ly/12NLY7S - View all 0 replies
-
Jim Van Meerten
$RMD - 100 % Barchart technical biy signal - 7 new highs and up 7.10% in the last month - Relative Strength Index 68.11% - View all 0 replies
-
ZetaKap
3 Highly Liquid Mid Cap Stocks Churning Out Profits http://bit.ly/Q30Apj $RMD $SYNT $WAT @ZetaKap - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Jim Van Meerten
RMD - 96% Barchart technical buy signal - 14 new highs and up 9.41% in the last month - Relative Strength Index 72.78% - View all 0 replies
LATEST REPLIES
-
- View all 1 replies
-
-
Chuck Carnevale
$RMD - What does $RMD's valuation look like? See F.A.S.T. Graphs: http://bit.ly/vyZFxU - View all 1 replies
-
